1 minute read
BRAVEST
BREAST AND CERVICAL CANCER AWARENESS MONTH
Breast cancer and cervical cancer, respectively, are the cancer cases with the highest numbers in Indonesia. This phenomenon indicates that Indonesian women do not have an adequate awareness and knowledge about these cancers, although both can be managed and prevented well if treated early.
Advertisement
Responding to this fact, SCORA CIMSA UI held Bravest (Breast and Cervical Cancer Awareness Month) from the 1st to the 24th of October 2020. Bravest consisted of online campaigns and a hybrid of webinar-talkshow as the main project.
The webinar session, titled “Let’s Know and Detect Breast and Cervical Cancer,” brought two speakers with expertise in breast oncology and gynecological oncology. The first speaker of the session was Dr. dr. Tofan Widya Utami, SpOG(K), a staff at the Department of Obstetrics and Gynecology FKUI-RSUPN Dr. Cipto Mangunkusumo. She brought a wholesome presentation about cervical cancer and the technologies concerning prevention and
early detection. The second speaker of the session was dr. Bob Andinata, SpB(K)Onk a member of The Indonesian Society of Surgical Oncology (PERABOI). He presented a thorough presentation about breast cancer and early detection of it-breast self-exam, clinical breast exam, and imaging technologies to confirm the diagnosis.
The talk show focused on the narration of a breast cancer’s survivor. The speaker for the session is Evilin Kumala, a breast cancer survivor from LovePink Indonesia. Evilin shared her story on receiving her diagnosis, the treatments, and the ways she coped with the verdict. “When I was stuck in the dark, a fellow warrior said to me that this too shall pass,” said Evilin, “The phrase runs deep within me. I learned that we have full control of our mind and body, and I managed to perform mindfulness.”
We sincerely hope that Bravest webinar session can enlighten our participants’ awareness and knowledge about breast and cervical cancer and help them develop a habit of breast self-exam and attending pap smear.
335 WEBINAR PARTICIPANTS
